These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37711518)

  • 21. Salivary and Serum Interleukin-6 Levels in Oral Premalignant Disorders and Squamous Cell Carcinoma: Diagnostic Value and Clinicopathologic Correlations.
    Dineshkumar T; Ashwini BK; Rameshkumar A; Rajashree P; Ramya R; Rajkumar K
    Asian Pac J Cancer Prev; 2016 Nov; 17(11):4899-4906. PubMed ID: 28032493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Verification of Saliva Matrix Metalloproteinase-1 as a Strong Diagnostic Marker of Oral Cavity Cancer.
    Chang YT; Chu LJ; Liu YC; Chen CJ; Wu SF; Chen CH; Chang IY; Wang JS; Wu TY; Dash S; Chiang WF; Chiu SF; Gou SB; Chien CY; Chang KP; Yu JS
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic salivary biomarkers in oral cancer and oral potentially malignant disorders and their relationships to risk factors - A systematic review.
    Piyarathne NS; Rasnayake RMSGK; Angammana R; Chandrasekera P; Ramachandra S; Weerasekera M; Yasawardene S; Abu-Eid R; Jayasinghe JAP; Gupta E
    Expert Rev Mol Diagn; 2021 Aug; 21(8):789-807. PubMed ID: 34148471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of salivary Cathepsin B in different histological grades among patients presenting with oral squamous cell carcinoma.
    Shabbir A; Waheed H; Ahmed S; Shaikh SS; Farooqui WA
    BMC Oral Health; 2022 Mar; 22(1):63. PubMed ID: 35260133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study of Candida species diversity among patients with oral squamous cell carcinoma and oral potentially malignant disorders.
    Sankari SL; Mahalakshmi K; Kumar VN
    BMC Res Notes; 2020 Oct; 13(1):488. PubMed ID: 33081839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.
    Bagan L; Sáez GT; Tormos MC; Labaig-Rueda C; Murillo-Cortes J; Bagan JV
    Clin Oral Investig; 2016 May; 20(4):737-43. PubMed ID: 26254143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
    Nandakumar A; Nataraj P; James A; Krishnan R; K M M
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
    Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
    Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
    S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
    Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
    Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of salivary matrix metalloproteinases- 12 (MMP- 12) levels among patients presenting with oral submucous fibrosis and oral squamous cell carcinoma.
    Saleem Z; Shaikh AH; Zaman U; Ahmed S; Majeed MM; Kazmi A; Farooqui WA
    BMC Oral Health; 2021 Apr; 21(1):205. PubMed ID: 33892690
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
    Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
    Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Salivary level of interleukin-8 in oral precancer and oral squamous cell carcinoma.
    Punyani SR; Sathawane RS
    Clin Oral Investig; 2013 Mar; 17(2):517-24. PubMed ID: 22526890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
    Hernández-Arenas YY; Támara-De Ávila JJ; Isaza-Guzmán DM; González-Pérez LV; Tobón-Arroyave SI
    J Oral Biosci; 2021 Jun; 63(2):217-223. PubMed ID: 33647453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head/neck squamous cell carcinoma (HNSCC): A systematic review and network meta-analysis.
    Khijmatgar S; Yong J; Rübsamen N; Lorusso F; Rai P; Cenzato N; Gaffuri F; Del Fabbro M; Tartaglia GM
    Jpn Dent Sci Rev; 2024 Dec; 60():32-39. PubMed ID: 38204964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of S100 A7 as a diagnostic biomarker in oral potentially malignant disorders and oral cancer.
    Sood A; Mishra D; Kharbanda OP; Chauhan SS; Gupta SD; Deo SSV; Yadav R; Ralhan R; Kumawat R; Kaur H
    J Oral Maxillofac Pathol; 2022; 26(2):166-172. PubMed ID: 35968185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary Interleukin-1 Levels in Oral Squamous Cell Carcinoma: A Case-Control Study.
    Vala D; Shah J; Purba AK; Mehta T; Mansata AV; Almalki SA; Makkad RS
    J Pharm Bioallied Sci; 2024 Feb; 16(Suppl 1):S346-S348. PubMed ID: 38595589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of protein-based salivary markers in the diagnosis of oral potentially malignant disorders: A systematic review and meta-analysis.
    Arroyo E; Donís SP; Petronacci CMC; Alves MGO; Mendía XM; Fernandes D; Pouso AIL; Bufalino A; Bravo López S; Sayáns MP
    Cancer Biomark; 2021; 32(4):411-424. PubMed ID: 34334380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
    Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salivary Biomarkers for Oral Cancer Detection: An Exploratory Systematic Review.
    Bastías D; Maturana A; Marín C; Martínez R; Niklander SE
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.